Lymphoma Predisposing Gene in an Extended Family: CD70 Signaling Defect.
Khusan KhodzhaevSema Buyukkapu BayRejin KebudiDidem AltindirekAysenur KayaYucel ErbilginOzden Hatirnaz NgAyca KiykimFunda Cipe ErolFeride Sen ZenginSinem FirtinaYuk Yin NgBasak Adakli AksoyMuge SayitogluPublished in: Journal of clinical immunology (2020)
Genome-wide sequencing studies in pediatric cancer cohorts indicate that about 10% of patients have germline mutations within cancer predisposition genes. Within this group, primary immune deficiencies take the priority regarding the vulnerability of the patients to infectious agents and the difficulties of cancer management. On the other hand, early recognition of these diseases may offer specific targeted therapies and hematopoietic stem cell transplantation as an option. Besides therapeutic benefits, early diagnosis will provide genetic counseling for the family members. Within this context, an extended family with multiple consanguineous marriages and affected individuals, who presented with combined immune deficiency (CID) and/or Hodgkin lymphoma phenotype, were examined by exome sequencing. A pathogenic homozygous missense CD70 variation was detected (NM_001252.5:c332C>T) in concordance with CD70 phenotype and familial segregation was confirmed. CD70 variations in patients with CID and malignancy have very rarely been reported. This paper reports extended family with multiple affected members with CID and malignancy carrying a missense CD70 variation, and reviews the rare cases reported in the literature. Primary immune deficiencies appear to be a potential cause for pediatric cancers. Better focusing on these inborn disorders to prevent or make an early diagnosis of malignant transformation and reduce mortalities is important.
Keyphrases
- genome wide
- end stage renal disease
- papillary thyroid
- newly diagnosed
- ejection fraction
- hodgkin lymphoma
- copy number
- nk cells
- peritoneal dialysis
- dna methylation
- chronic kidney disease
- squamous cell
- prognostic factors
- randomized controlled trial
- childhood cancer
- photodynamic therapy
- systematic review
- climate change
- intellectual disability
- emergency department
- squamous cell carcinoma
- smoking cessation
- hepatitis c virus
- gene expression
- oxidative stress
- antiretroviral therapy
- genome wide identification
- adverse drug